Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease
© 2024. The Author(s)..
BACKGROUND: Kawasaki disease (KD) is an acute systemic vasculitis of unknown etiology that predominantly affects children, and no specific diagnostic biomarkers for KD are available. Platelet-derived growth factor CC (PDGF-CC) is a peptide with angiogenic properties that has been amply demonstrated to play a critical role in the cardiovascular system. This study aimed to investigate the serum expression of PDGF-CC in children with KD and to evaluate the ability of PDGF-CC to diagnose KD.
METHODS: A total of 96 subjects, including 59 KD patients, 17 febrile controls (FC), and 20 healthy controls (HC), were enrolled. Serum levels of PDGF-CC were measured via enzyme-linked immunosorbent assay. The associations between PDGF-CC and clinical laboratory parameters were investigated by correlation analysis. The diagnostic performance was assessed by receiver operating characteristic (ROC) curve analysis.
RESULTS: Serum PDGF-CC levels in the KD group were significantly higher than in the FC and HC groups. Serum PDGF-CC levels in the KD group were positively correlated with white blood cell counts, percentage of neutrophils, IL-2, IL-12p70, TNF-α, and IL-1β levels, and negatively correlated with the percentage of lymphocytes. In the analysis of ROC curves, the area under the curve was 0.796 (95% confidence interval 0.688-0.880; P < 0.0001) for PDGF-CC and increased to 0.900 (95% confidence interval 0.808-0.957; P < 0.0001) in combination with white blood cell counts and C-reactive protein.
CONCLUSIONS: PDGF-CC is a potential biomarker for KD diagnosis, and the combination with white blood cell counts and C-reactive protein can further improve diagnostic performance.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
---|---|
Enthalten in: |
Italian journal of pediatrics - 50(2024), 1 vom: 25. Jan., Seite 16 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Jing [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.01.2024 Date Revised 29.01.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s13052-024-01580-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367638029 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367638029 | ||
003 | DE-627 | ||
005 | 20240129232158.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240126s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13052-024-01580-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n1274.xml |
035 | |a (DE-627)NLM367638029 | ||
035 | |a (NLM)38273388 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Jing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Serum levels of PDGF-CC as a potential biomarker for the diagnosis of Kawasaki disease |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.01.2024 | ||
500 | |a Date Revised 29.01.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Kawasaki disease (KD) is an acute systemic vasculitis of unknown etiology that predominantly affects children, and no specific diagnostic biomarkers for KD are available. Platelet-derived growth factor CC (PDGF-CC) is a peptide with angiogenic properties that has been amply demonstrated to play a critical role in the cardiovascular system. This study aimed to investigate the serum expression of PDGF-CC in children with KD and to evaluate the ability of PDGF-CC to diagnose KD | ||
520 | |a METHODS: A total of 96 subjects, including 59 KD patients, 17 febrile controls (FC), and 20 healthy controls (HC), were enrolled. Serum levels of PDGF-CC were measured via enzyme-linked immunosorbent assay. The associations between PDGF-CC and clinical laboratory parameters were investigated by correlation analysis. The diagnostic performance was assessed by receiver operating characteristic (ROC) curve analysis | ||
520 | |a RESULTS: Serum PDGF-CC levels in the KD group were significantly higher than in the FC and HC groups. Serum PDGF-CC levels in the KD group were positively correlated with white blood cell counts, percentage of neutrophils, IL-2, IL-12p70, TNF-α, and IL-1β levels, and negatively correlated with the percentage of lymphocytes. In the analysis of ROC curves, the area under the curve was 0.796 (95% confidence interval 0.688-0.880; P < 0.0001) for PDGF-CC and increased to 0.900 (95% confidence interval 0.808-0.957; P < 0.0001) in combination with white blood cell counts and C-reactive protein | ||
520 | |a CONCLUSIONS: PDGF-CC is a potential biomarker for KD diagnosis, and the combination with white blood cell counts and C-reactive protein can further improve diagnostic performance | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biomarker | |
650 | 4 | |a Diagnostic markers | |
650 | 4 | |a Kawasaki disease | |
650 | 4 | |a Platelet-derived growth factor CC | |
650 | 7 | |a platelet-derived growth factor C |2 NLM | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Platelet-Derived Growth Factor |2 NLM | |
650 | 7 | |a Lymphokines |2 NLM | |
700 | 1 | |a Yang, Penghui |e verfasserin |4 aut | |
700 | 1 | |a Liu, Yihao |e verfasserin |4 aut | |
700 | 1 | |a Chen, Zhuo |e verfasserin |4 aut | |
700 | 1 | |a Wu, Jinhui |e verfasserin |4 aut | |
700 | 1 | |a Feng, Siqi |e verfasserin |4 aut | |
700 | 1 | |a Yi, Qijian |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Italian journal of pediatrics |d 2008 |g 50(2024), 1 vom: 25. Jan., Seite 16 |w (DE-627)NLM188982507 |x 1824-7288 |7 nnns |
773 | 1 | 8 | |g volume:50 |g year:2024 |g number:1 |g day:25 |g month:01 |g pages:16 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13052-024-01580-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 50 |j 2024 |e 1 |b 25 |c 01 |h 16 |